Hydroxytyrosol restores proper insulin signaling in an astrocytic model of Alzheimer's disease

BioFactors

Volumn 43, Issue 4, 2017, Pages 540-548

  Crespo, M Carmen ^a   Tomé Carneiro, Joao ^a   Pintado, Cristina ^b   Dávalos, Alberto ^a   Visioli, Francesco ^a,c   Burgos Ramos, Emma ^b  

^a CSIC   (Spain)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Alzheimer's disease; astrocytes; hydroxytyrosol; insulin resistance; Mediterranean diet

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; GLUCOSE TRANSPORTER 2; HYDROXYTYROSOL; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; OLIVE OIL; PROTEIN KINASE B; PROTEIN P85; 3,4-DIHYDROXYPHENYLETHANOL; PHENETHYL ALCOHOL;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL PROTECTION; CELL VIABILITY; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOTOXICITY; DENSITOMETRY; DRUG MECHANISM; ENZYME ACTIVATION; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; WESTERN BLOTTING;

ALZHEIMER DISEASE; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; INSULIN; PHENYLETHYL ALCOHOL; RATS; SIGNAL TRANSDUCTION;

EID: 85016017050     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1356     Document Type: Article

References (71)

1. Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., et al. (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 9, 63–75 e62.
2. Wimo, A., Guerchet, M., Ali, G. C., Wu, Y. T., Prina, A. M., et al. (2016) The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement. 13, 1–7.
3. Walsh, D. M. and Selkoe, D. J. (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181–193.
4. Gatta, E., Lefebvre, T., Gaetani, S., dos Santos, M., Marrocco, J., et al. (2016) Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease. Pharmacol. Res. 105, 186–197.
5. Alonso, A. D., Grundke-Iqbal, I., Barra, H. S., and Iqbal, K. (1997) Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc. Natl. Acad. Sci. USA 94, 298–303.
6. Selkoe, D. J. and Hardy, J. (2016) The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol. Med. 8, 595–608.
7. Okamoto, T., Takeda, S., Murayama, Y., Ogata, E., and Nishimoto, I. (1995) Ligand-dependent G protein coupling function of amyloid transmembrane precursor. J. Biol. Chem. 270, 4205–4208.
8. Gandy, S. (2005) The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J. Clin. Invest. 115, 1121–1129.
9. Yamada, K. and Nabeshima, T. (2000) Animal models of Alzheimer's disease and evaluation of anti-dementia drugs. Pharmacol. Ther. 88, 93–113.
10. Vagelatos, N. T. and Eslick, G. D. (2013) Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol. Rev. 35, 152–160.
11. Yang, Y. and Song, W. (2013) Molecular links between Alzheimer's disease and diabetes mellitus. Neuroscience 250, 140–150.
12. Greene, A., Ng, J., Shepherd, L., and Carey, K. (2015) Alzheimer's disease and type 2 diabetes: what is the connection? Consult. Pharm. 30, 112–115.
13. Haan, M. N. (2006) Therapy insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease. Nat. Clin. Pract. Neurol. 2, 159–166.
14. Profenno, L. A., Porsteinsson, A. P., and Faraone, S. V. (2010) Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol. Psychiatry 67, 505–512.
15. Lebovitz, H. E. (2001) Insulin resistance: definition and consequences. Exp. Clin. Endocrinol. Diabetes 109(Suppl 2), S135–S148.
16. Zhao, W. Q. and Townsend, M. (2009) Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. Biochim. Biophys. Acta, 1792, 482–496.
17. Moloney, A. M., Griffin, R. J., Timmons, S., O'Connor, R., Ravid, R., et al. (2010) Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol. Aging, 31, 224–243.
18. Talbot, K., Wang, H. Y., Kazi, H., Han, L. Y., Bakshi, K. P., et al. (2012) Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122, 1316–1338.
19. Accardi, G., Caruso, C., Colonna-Romano, G., Camarda, C., Monastero, R., et al. (2012) Can Alzheimer disease be a form of type 3 diabetes? Rejuvenation Res. 15, 217–221.
20. Kandimalla Thirumala, R. V. and Reddy, P. H. (2016) Is Alzheimer's disease a type 3 diabetes? A critical appraisal. Biochim. Biophys. Acta. pii: S0925-4439(16)30215-0. doi: 10.1016/j.bbadis.2016.08.018.
21. Jimenez-Palomares, M., Ramos-Rodriguez, J. J., Lopez-Acosta, J. F., Pacheco-Herrero, M., Lechuga-Sancho, A. M., et al. (2012) Increased Abeta production prompts the onset of glucose intolerance and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 302, E1373–E1380.
22. Brown, A. M. and Ransom, B. R. (2007) Astrocyte glycogen and brain energy metabolism. Glia, 55, 1263–1271.
23. Muller, M. S. (2014) Functional impact of glycogen degradation on astrocytic signalling. Biochem. Soc. Trans. 42, 1311–1315.
24. Kamphuis, W., Middeldorp, J., Kooijman, L., Sluijs, J. A., Kooi, E. J., et al. (2014) Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease. Neurobiol. Aging, 35, 492–510.
25. Osborn, L. M., Kamphuis, W., Wadman, W. J., and Hol, E. M. (2016) Astrogliosis: an integral player in the pathogenesis of Alzheimer's disease. Prog. Neurobiol. 144, 121–141.
26. Zhang, Q., Guo, S., Zhang, X., Tang, S., Wang, L., et al. (2015) Amyloid beta oligomer-induced ERK1/2-dependent serine 636/639 phosphorylation of insulin receptor substrate-1 impairs insulin signaling and glycogen storage in human astrocytes. Gene 561, 76–81.
27. Han, X., Yang, L., Du, H., Sun, Q., Wang, X., et al. (2016) Insulin attenuates beta-amyloid-associated insulin/Akt/EAAT signaling perturbations in human astrocytes. Cell. Mol. Neurobiol. 36, 851–864.
28. van de Rest, O., Berendsen, A. A., Haveman-Nies, A., and de Groot, L. C. (2015) Dietary patterns, cognitive decline, and dementia: a systematic review. Adv. Nutr. 6, 154–168.
29. Martinez-Lapiscina, E. H., Clavero, P., Toledo, E., San Julian, B., Sanchez-Tainta, A., et al. (2013) Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial. J. Nutr. Health Aging 17, 544–552.
30. Herrera Acosta, E., Alonso Suárez Pérez, J., Aguilera Arjona, J., and Visioli, F. (2016) An olive polyphenol-based nutraceutical improves cutaneous manifestations of psoriasis in humans. PharmaNutrition, 4, 151–153.
31. Piroddi, M., Albini, A., Fabiani, A., Giovannelli, R., Luceri, L., Natella, C., et al. (2016) Nutrigenomics of extra-virgin olive oil: a review. Biofactors 43, 17–41.
32. Visioli, F. and Bernardini, E. (2011) Extra virgin olive oil's polyphenols: biological activities. Curr Pharm Des. 17, 786–804.
33. Rodriguez-Morato, J., Xicota, L., Fito, M., Farre, M., Dierssen, M., et al. (2015) Potential role of olive oil phenolic compounds in the prevention of neurodegenerative diseases. Molecules 20, 4655–4680.
34. St-Laurent-Thibault, C., Arseneault, M., Longpre, F., and Ramassamy, C. (2011) Tyrosol and hydroxytyrosol, two main components of olive oil, protect N2a cells against amyloid-beta-induced toxicity. Involvement of the NF-kappaB signaling. Curr. Alzheimer Res. 8, 543–551.
35. Peng, Y., Hou, C., Yang, Z., Li, C., Jia, L., et al. (2016) Hydroxytyrosol mildly improve cognitive function independent of APP processing in APP/PS1 mice. Mol. Nutr. Food Res. 60, 2331–2342.
36. Pirozzi, C., Lama, A., Simeoli, R., Paciello, O., Pagano, T. B., et al. (2016) Hydroxytyrosol prevents metabolic impairment reducing hepatic inflammation and restoring duodenal integrity in a rat model of NAFLD. J. Nutr. Biochem. 30, 108–115.
37. de Bock, M., Derraik, J. G., Brennan, C. M., Biggs, J. B., Morgan, P. E., et al. (2013) Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial. PLoS One, 8, e57622.
38. Benda, P., Lightbody, J., Sato, G., Levine, L., and Sweet, W. (1968) Differentiated rat glial cell strain in tissue culture. Science 161, 370–371.
39. Takanaga, H., Yoshitake, T., Hara, S., Yamasaki, C., and Kunimoto, M. (2004) cAMP-induced astrocytic differentiation of C6 glioma cells is mediated by autocrine interleukin-6. J. Biol. Chem. 279, 15441–15447.
40. Ma, W. W., Hou, C. C., Zhou, X., Yu, H. L., Xi, Y. D., et al. (2013) Genistein alleviates the mitochondria-targeted DNA damage induced by beta-amyloid peptides 25-35 in C6 glioma cells. Neurochem. Res. 38, 1315–1323.
41. Catalan, U., Lopez de Las Hazas, M. C., Rubio, L., Fernandez-Castillejo, S., Pedret, A., et al. (2015) Protective effect of hydroxytyrosol and its predominant plasmatic human metabolites against endothelial dysfunction in human aortic endothelial cells. Mol. Nutr. Food Res. 59, 2523–2536.
42. Gual, P., Le Marchand-Brustel, Y., and Tanti, J. F. (2005) Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87, 99–109.
43. Herschkovitz, A., Liu, Y. F., Ilan, E., Ronen, D., Boura-Halfon, S., et al. (2007) Common inhibitory serine sites phosphorylated by IRS-1 kinases, triggered by insulin and inducers of insulin resistance. J. Biol. Chem. 282, 18018–18027.
44. Ouyang, Y. B., Zhang, X. H., He, Q. P., Wang, G. X., Siesjo, B. K., et al. (2000) Differential phosphorylation at Ser473 and Thr308 of Akt-1 in rat brain following hypoglycemic coma. Brain Res. 876, 191–195.
45. Thorens, B. (2015) GLUT2, glucose sensing and glucose homeostasis. Diabetologia, 58, 221–232.
46. Arluison, M., Quignon, M., Nguyen, P., Thorens, B., Leloup, C., et al. (2004) Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain—an immunohistochemical study. J. Chem. Neuroanat. 28, 117–136.
47. Harrington, L. S., Findlay, G. M., and Lamb, R. F. (2005) Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem. Sci. 30, 35–42.
48. Di Domenico, F., Barone, E., Perluigi, M., and Butterfield, D. A. (2016) The triangle of death in Alzheimer's disease brain: the aberrant cross-talk among energy metabolism, mammalian target of rapamycin signaling, and protein homeostasis revealed by redox proteomics. Antioxid. Redox Signal. doi:10.1089/ars.2016.6759.
49. Solfrizzi, V. and Panza, F. (2014) Mediterranean diet and cognitive decline. A lesson from the whole-diet approach: what challenges lie ahead? J. Alzheimers Dis. 39, 283–286.
50. Mattson, M. P., Begley, J. G., Mark, R. J., and Furukawa, K. (1997) Abeta25-35 induces rapid lysis of red blood cells: contrast with Abeta1-42 and examination of underlying mechanisms. Brain Res. 771, 147–153.
51. Zhao, X., Yuan, L., Yu, H., Xi, Y., Ma, W., et al. (2014) Genistein inhibited amyloid-beta induced inflammatory damage in C6 glial cells. Arch. Med. Res. 45, 152–157.
52. Xing, Z. G., Yu, G. D., Qin, L., Jiang, F., and Zhao, W. H. (2015) Effects and mechanism of lipoic acid on beta-amyloid-intoxicated C6 glioma cells. Genet. Mol. Res. 14, 13880–13888.
53. Lu, P., Mamiya, T., Lu, L., Mouri, A., Ikejima, T., et al. (2012) Xanthoceraside attenuates amyloid beta peptide(2)(5)(-)(3)(5)-induced learning and memory impairments in mice. Psychopharmacology (Berl) 219, 181–190.
54. Schaffer, S., Muller, W. E., and Eckert, G. P. (2010) Cytoprotective effects of olive mill wastewater extract and its main constituent hydroxytyrosol in PC12 cells. Pharmacol. Res. 62, 322–327.
55. Gonzalez-Correa, J. A., Navas, M. D., Lopez-Villodres, J. A., Trujillo, M., Espartero, J. L., et al. (2008) Neuroprotective effect of hydroxytyrosol and hydroxytyrosol acetate in rat brain slices subjected to hypoxia-reoxygenation. Neurosci. Lett. 446, 143–146.
56. Zheng, A., Li, H., Xu, J., Cao, K., Pu, W., et al. (2015) Hydroxytyrosol improves mitochondrial function and reduces oxidative stress in the brain of db/db mice: role of AMP-activated protein kinase activation. Br. J. Nutr. 113, 1667–1676.
57. Qiao, L. Y., Goldberg, J. L., Russell, J. C., and Sun, X. J. (1999) Identification of enhanced serine kinase activity in insulin resistance. J. Biol. Chem. 274, 10625–10632.
58. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C. Z., Uysal, K. T., et al. (2002) A central role for JNK in obesity and insulin resistance. Nature 420, 333–336.
59. Jin, Y., Yan, E. Z., Fan, Y., Zong, Z. H., Qi, Z. M., et al. (2005) Sodium ferulate prevents amyloid-beta-induced neurotoxicity through suppression of p38 MAPK and upregulation of ERK-1/2 and Akt/protein kinase B in rat hippocampus. Acta Pharmacol. Sin. 26, 943–951.
60. Meng, Y., Xu, H., Wang, R., Ji, Z., Yu, S., et al. (2002) [Impairment of signal transduction pathway on neuronal survival in brains of Alzheimer's disease]. Zhonghua Bing Li Xue Za Zhi, 31, 502–505.
61. Pei, Y. H., Chen, J., Xie, L., Cai, X. M., Yang, R. H., et al. (2016) Hydroxytyrosol protects against myocardial ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Mediators Inflamm. 2016, 1232103, 1–9.
62. Martin, M. A., Ramos, S., Granado-Serrano, A. B., Rodriguez-Ramiro, I., Trujillo, M., et al. (2010) Hydroxytyrosol induces antioxidant/detoxificant enzymes and Nrf2 translocation via extracellular regulated kinases and phosphatidylinositol-3-kinase/protein kinase B pathways in HepG2 cells. Mol. Nutr. Food Res. 54, 956–966.
63. Zou, X., Feng, Z., Li, Y., Wang, Y., Wertz, K., et al. (2012) Stimulation of GSH synthesis to prevent oxidative stress-induced apoptosis by hydroxytyrosol in human retinal pigment epithelial cells: activation of Nrf2 and JNK-p62/SQSTM1 pathways. J. Nutr. Biochem. 23, 994–1006.
64. Chong, Z. Z., Li, F., and Maiese, K. (2005) Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. Histol. Histopathol. 20, 299–315.
65. Chen, Z. and Zhong, C. (2013) Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog. Neurobiol. 108, 21–43.
66. Hmimed, S., Belarbi, M., and Visioli, F. (2016) Hydroxytyrosol augments the redox status of high fat diet-fed rats. PharmaNutrition, 4, 139–142.
67. Poudyal, H., Lemonakis, N., Efentakis, P., Gikas, E., Halabalaki, M., et al. (2016) Hydroxytyrosol ameliorates metabolic, cardiovascular and liver changes in a rat model of diet-induced metabolic syndrome: pharmacological and metabolism-based investigation. Pharmacol. Res. 117, 32–45.
68. Lemonakis, N., Poudyal, H., Halabalaki, M., Brown, L., Tsarbopoulos, A., et al. (2017) The LC-MS-based metabolomics of hydroxytyrosol administration in rats reveals amelioration of the metabolic syndrome. J. Chromatogr.: B Anal. Technol. Biomed. Life Sci. 1041–1042, 45–59.
69. Fan, S., Zhang, B., Luan, P., Gu, B., Wan, Q., et al. (2015) PI3K/AKT/mTOR/p70S6K pathway is involved in Abeta25-35-induced autophagy. Biomed. Res. Int. 2015, 161020, 1–9.
70. Tramutola, A., Triplett, J. C., Di Domenico, F., Niedowicz, D. M., Murphy, M. P., et al. (2015) Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD. J. Neurochem. 133, 739–749.
71. Ma, Y. Q., Wu, D. K., and Liu, J. K. (2013) mTOR and tau phosphorylated proteins in the hippocampal tissue of rats with type 2 diabetes and Alzheimer's disease. Mol. Med. Rep. 7, 623–627.